Membrane Or Diffusion Barrier Patents (Class 424/424)
-
Patent number: 7723086Abstract: An apparatus for encapsulating cells is disclosed. According to one embodiment, the apparatus includes an indirect-pumping dispenser for dispensing a cell suspension into an encapsulation solution through an outlet of the dispenser. The apparatus also includes a dipping mechanism that is attachable to the outlet of the dispenser. The dipping mechanism is adapted to dip the dispenser outlet in the encapsulation solution to allow the cell suspension dispensed thereat to come into contact with the encapsulation solution.Type: GrantFiled: June 16, 2004Date of Patent: May 25, 2010Assignee: Agency for Science, Technology + ResearchInventors: Hanry Yu, Hai Ting Ho, Jing Zhang
-
Patent number: 7723303Abstract: This invention provides novel active agents (e.g. peptides, small organic molecules, amino acid pairs, etc.) peptides that ameliorate one or more symptoms of atherosclerosis and/or other pathologies characterized by an inflammatory response. In certain embodiment, the peptides resemble a G* amphipathic helix of apolipoprotein J. The agents are highly stable and readily administered via an oral route.Type: GrantFiled: April 18, 2006Date of Patent: May 25, 2010Assignees: The Regents of the University of California, The UAB Research FoundationInventors: Alan M. Fogelman, Mohamad Navab, Gattadahalli M. Anantharamaiah
-
Publication number: 20100124564Abstract: The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.Type: ApplicationFiled: November 13, 2009Publication date: May 20, 2010Inventors: Laura Martinson, Chad Green, Evert Kroon, Alan Agulnick, Olivia Kelly, Emmanuel E. Baetge
-
Patent number: 7718351Abstract: Methods and apparatuses involving biocompatible structures for tissue engineering and organ replacement and, more specifically, biocompatible structures formed by three-dimensional fabrication, are described. In some embodiments, the biocompatible structures are scaffolds for cells that can be used as tissue engineering templates and/or as artificial organs. The structures may be three-dimensional and can mimic the shapes and dimensions of tissues and/or organs, including the microarchitecture and porosities of the tissues and organs. Pores in the structure may allow delivery of molecules across the structure, and may facilitate cell migration and/or generation of connective tissue between the structure and its host environment. Structures of the invention can be implanted into a mammal and/or may be used ex vivo as bioartificial assist devices.Type: GrantFiled: March 14, 2006Date of Patent: May 18, 2010Assignee: Agency for Science, Technology & ResearchInventors: Jackie Y. Ying, Shyi-Herng Kan, Jeremy Loh Ming Hock, Karl Schumacher, James Tseng-Ming Hsieh
-
Patent number: 7709631Abstract: This application describes a bioresorbable biocellulose suitable for medical and surgical applications. In particular, the invention describes periodate oxidized microbial cellulose that can be produced to have any mechanical and degradation profile, depending on the desired application of the oxidized cellulose.Type: GrantFiled: January 31, 2007Date of Patent: May 4, 2010Assignee: Xylos CorporationInventors: Jeremy J. Harris, Gonzalo Serafica, Christopher J. Damien, Heather R. Nonnenmann
-
Patent number: 7708979Abstract: Thermogelling polymers are described containing poly (n-isopropyl acrylamide). Solutions of this polymer, copolymers or mixtures of the polymer with a second polymer such as poly(ethylene glycol), poly (vinyl pyrrolidone) or poly(vinyl alcohol) are liquids at room temperature and solids at body temperature. Thus, also provided are methods of implanting a hydrogel into a mammal by injecting the solution as a liquid at a temperature below body temperature into a selected site in the mammal at a temperature below body temperature, which then undergoes thermal phase transition to form a solid hydrogel in situ in the body as the implant warms to body temperature. Methods for using these thermal gelling materials in various applications including nucleus pulposus replacement/augmentation, wound care, disk replacement, cartilage replacement, joint replacement, surgical barriers, gastrointestinal devices, cosmetic and reconstructive surgery, and breast enlargement are also provided.Type: GrantFiled: April 30, 2004Date of Patent: May 4, 2010Assignees: Synthes USA, LLC, Drexel UniversityInventors: Anthony M. Lowman, Michele S. Marcolongo, Alastair J. T. Clemow
-
Publication number: 20100098742Abstract: Methods and materials for making complex, living, vascularized tissues for organ and tissue replacement, especially complex and/or thick structures, such as liver tissue is provided. Tissue lamina is made in a system comprising an apparatus having (a) a first mold or polymer scaffold, a semi-permeable membrane, and a second mold or polymer scaffold, wherein the semi-permeable membrane is disposed between the first and second molds or polymer scaffolds, wherein the first and second molds or polymer scaffolds have means defining microchannels positioned toward the semi-permeable membrane, wherein the first and second molds or polymer scaffolds are fastened together; and (b) animal cells. Methods for producing complex, three-dimensional tissues or organs from tissue lamina are also provided.Type: ApplicationFiled: June 28, 2002Publication date: April 22, 2010Inventors: Joseph P. Vacanti, Young-Moon Michael Shin, Jennifer Ogilvie, Alexander Sevy, Tomoyuki Maemura, Osamu Ishii, Mohammad Reza Kaazempur-Mofrad, Jeffrey T. Borenstein, Kevin R. King, Chiao-Chun Wang, Eli Weinberg
-
Publication number: 20100098743Abstract: An object is to overcome the disadvantages of a conventional lyophilized amniotic membrane or the like which causes damages in a cell membrane or an amniotic membrane tissue and is therefore not suitable for use as a substitute membrane for a membrane tissue in a living body, and to provide a novel medical substitute membrane composed of a dried amniotic membrane, which can be used as a substitute membrane for a membrane tissue in a living body. The dried amniotic membrane is produced by drying a fresh amniotic membrane, which envelopes an embryo of an animal including human, and can be used as a substitute membrane for a membrane tissue in a living body; the dried amniotic membrane is dehydrated and dried so that the dried amniotic membrane can be stored in a dry air in a sterile state; when hydrated again by immersing in water or a buffer solution, the amniotic membrane still has an epithelial cell, a basement membrane and a connective tissue which constitute the fresh amniotic membrane.Type: ApplicationFiled: February 21, 2008Publication date: April 22, 2010Inventors: Toshio Nikaido, Motonori Okabe, Toshiko Yoshida, Shunro Endo, Nakamasa Hayashi, Shigeru Saito
-
Patent number: 7700659Abstract: Implantable devices formed of or coated with a material that includes a polymer having a non-fouling acrylate or methacrylate polymer are provided. The implantable device can be used for treating or preventing a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, patent foramen ovale, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.Type: GrantFiled: March 24, 2005Date of Patent: April 20, 2010Assignee: Advanced Cardiovascular Systems, Inc.Inventor: Stephen D. Pacetti
-
Patent number: 7695958Abstract: To provide a cell-filled device that is suitable for use in, for example, an implantable or circulation type hybrid artificial organ. In a cell-filled device including hollow fiber membranes whose hollow portions are filled with cells, the hollow fiber membranes have modified cross sections, and a cell aggregate provided in each of the hollow portions has cells formed into two or more layers in arbitrary directions, provided that the distance from an arbitrary point of the cell aggregate to the nearest inner wall of hollow fiber membrane is less than 75 ?m. This cell-filled device enables effective use of cells without the necrosis thereof. Further, according to the present invention, there is provided a method of manufacturing the cell-filled device.Type: GrantFiled: August 28, 2003Date of Patent: April 13, 2010Assignee: Asahi Kasei Kuraray Medical Co., Ltd.Inventors: Kazumori Funatsu, Kohji Nakazawa, Hiroshi Mizumoto, Junji Fukuda, Mikitomo Yasutake
-
Patent number: 7695967Abstract: The present invention provides a novel substrate for use in growing cells and for the study of mechanobiology. The membrane of the present invention comprises appropriate microtopography and surface chemical modifications to facilitate the production of adherent and oriented cells that phenotypically resemble cells in vivo.Type: GrantFiled: February 22, 2005Date of Patent: April 13, 2010Assignee: The Board of Trustees of the University of IllinoisInventors: Brenda Russell, Tejal A. Desai
-
Publication number: 20100074941Abstract: Absorbable barrier composites are designed for modulated gas and water permeability depending on clinical use and are formed of at least two physicochemically distinct components, one of which is a film adjoined to a knitted mesh and/or electrostatically spun, non-woven fabric. Depending on the physicochemical properties of the barrier composite, it can be used in neurological and urinogenital surgical procedures as well as tissue engineering and/or as physical barriers to prevent adhesion formation following several types of surgical procedures.Type: ApplicationFiled: September 24, 2008Publication date: March 25, 2010Inventor: Shalaby W. Shalaby
-
Patent number: 7674477Abstract: The present invention provides a bone in-growth surface for implants which has a structure for delivering therapeutic agents to surrounding bone and tissue. The bone in-growth surface may comprise scaffolding and a controlled-permeability layer which contains the therapeutic agents in a variety of reservoirs. The porosity of the scaffolding may be controllable from zero porosity to essentially a fully porous material.Type: GrantFiled: January 5, 2006Date of Patent: March 9, 2010Assignee: University of Notre Dame du LacInventors: Steven R. Schmid, Glen L. Niebur, Dale R. Sumner
-
Patent number: 7664282Abstract: An embodiment provides a seal for retaining a hearing device within the ear canal comprising a curved shell having an opening at a shell apex portion. The shell defines a cavity for retention of a device component. An interior surface of a shell wall has a scalloped shape configured to distribute compressive forces applied to the shell perimeter such that when the shell is positioned in the canal, the shell wall conforms to the shape of the canal to maintain an acoustical seal between a shell exterior surface and the canal walls. The scalloped shape can be configured to produce a substantially constant amount of inward deformation of a shell wall independent of a force application point on a shell perimeter. The shell can include a coating to retain the seal in the canal and/or to promote asparagine growth into the coating to fastenly retain the seal in the canal.Type: GrantFiled: September 27, 2005Date of Patent: February 16, 2010Assignee: InSound Medical, Inc.Inventors: Richard C Urso, Adnan Shennib, Greg Anderson, Sunder Ram, Robert Schindler, Ian Day, James Buckley
-
Publication number: 20100034866Abstract: Methods disclosed include methods of treating T1DM, said method comprising delivering a therapeutic amount of ?-MSC to a subject in need thereof. Further disclosed are fusion cells comprising and MSC and a second cell wherein the nuclei of the MSC and the second cell are not fused in the fusion cell.Type: ApplicationFiled: September 19, 2007Publication date: February 11, 2010Inventor: Christof Westenfelder
-
Patent number: 7659219Abstract: The present invention is directed to implantable bioabsorbable non-woven self-cohered web materials having a high degree of porosity. The web materials are very supple and soft, while exhibiting proportionally increased mechanical strength in one or more directions. The web materials often possess a high degree of loft. The web materials can be formed into a variety of shapes and forms suitable for use as implantable medical devices or components thereof. The web materials possess haemostatic properties.Type: GrantFiled: January 30, 2006Date of Patent: February 9, 2010Assignee: Gore Enterprise Holdings, Inc.Inventors: Roy Biran, Edward H. Cully, Ted R. Farnsworth, Charles Flynn, Philip P. Off, Charles F. White
-
Patent number: 7655584Abstract: The present invention is directed to implantable bioabsorbable non-woven self-cohered web materials having a very high degree of porosity. The web materials are very supple and soft, while exhibiting proportionally increased mechanical strength in one or more directions. The web materials often possess a high degree of loft. The web materials can be formed into a variety of shapes and forms suitable for use as implantable medical devices or components thereof. In some embodiments, the web materials exhibit significant thrombogenic properties.Type: GrantFiled: July 29, 2005Date of Patent: February 2, 2010Assignee: Gore Enterprise Holdings, Inc.Inventors: Roy Biran, Edward H. Cully, Ted R. Farnsworth, Charles Flynn, Charles F. White
-
Patent number: 7655288Abstract: The present invention is directed to implantable bioabsorbable non-woven self-cohered web materials having a high degree of porosity. The web materials are very supple and soft, while exhibiting proportionally increased mechanical strength in one or more directions. The web materials often possess a high degree of loft. The web materials can be formed into a variety of shapes and forms suitable for use as implantable medical devices or components thereof.Type: GrantFiled: July 29, 2005Date of Patent: February 2, 2010Assignee: Gore Enterprise Holdings, Inc.Inventors: Ann M. Bauman, Ted R. Farnsworth, Charles Flynn, Daniel S. Gabrys, Charles F. White
-
Patent number: 7648711Abstract: A sustained release formulation by using dimeticone as the dispersion medium, which includes active ingredient (e.g., drugs against parasites, insecticides, NSAIDs, antibiotics, sex hormone like agents or oily soluble vitamins) and dimeticone as the medium. Suitable stabilizer, antioxidant, local analgesics and material for sustained release may be added. The formulation is bio-compatible, stable and injectable.Type: GrantFiled: October 8, 2003Date of Patent: January 19, 2010Inventors: Yuwan Wang, Zhende Pan, Xiaoxi Dai
-
Patent number: 7649023Abstract: An improved drug delivery composition and method of use is disclosed. The composition comprises one or more biodegradable block copolymer drug carriers; and a reconstitution enhancing and enabling agent comprising polyethylene glycol (PEG), a PEG derivative or a mixture of PEG and a PEG derivative. The composition can be administered as is or after being be dissolved or rapidly reconstituted in an aqueous vehicle to afford a homogeneous solution or uniform colloidal systems.Type: GrantFiled: June 28, 2002Date of Patent: January 19, 2010Assignee: Novartis AGInventors: Chung Shih, Gaylen M. Zentner
-
Patent number: 7648728Abstract: A method for producing a calcium phosphate bone filler by preparing a mixed liquid comprising a calcium solution and a phosphoric acid solution in such a manner that a substrate of calcium phosphate exists in the mixed liquid, thereby precipitating calcium phosphate on the substrate to form a coating layer, and heat-treating the resultant composite comprising the substrate and the coating layer.Type: GrantFiled: July 11, 2005Date of Patent: January 19, 2010Assignee: Hoya CorporationInventors: Akira Yamamoto, Yusuke Iimori, Yuko Miyazaki
-
Patent number: 7642300Abstract: A composition is disclosed which comprises (i) a macromer prepared by reacting an unsaturated diacid having a carbon-carbon double bond and a saturated diacid, and (ii) a bioactive ceramic grafted to the macromer. In one embodiment, the unsaturated diacid having a carbon-carbon double bond is fumaric acid, the saturated diacid is compatible with fumaric acid and poly(propylene fumarate) such as succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and mixtures thereof, and the bioactive ceramic is hydroxyapatite. In another embodiment, hydroxyapatite is grafted with a biodegradable and crosslinkable macromer comprising silane units alternating with furnarate and adipate units.Type: GrantFiled: June 29, 2004Date of Patent: January 5, 2010Inventors: Michael J. Yaszemski, Bradford L. Currier, Esmaiel Jabbari, Lichun Lu
-
Publication number: 20090287072Abstract: The disclosure provides for a biocompatible, thromboresistant coating including a chalcogenide compound that induces nitric oxide formation; and a biocompatible matrix incorporating the chalcogenide compound. Devices incorporating such coatings, and methods of making and using such coatings are also disclosed herein.Type: ApplicationFiled: December 1, 2006Publication date: November 19, 2009Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, MICHIGAN CRITICAL CARE CONSULTANTS, INC. (MC3)Inventors: Mark E. Meyerhoff, Wansik Cha, Sang-Yeul Hwang, Melissa M. Reynolds
-
Patent number: 7618646Abstract: The invention relates to porous matrices based on a biologically compatible polymer or polymer mixture, to a cell implantation that is established on said matrices and to additional cell implantation based on cell mixtures of hepatocytes and islets of Langerhans. The invention also relates to a method for producing porous matrices, to matrices obtained according to said method and to a special method for obtaining cells for the inoculation of an implantable matrix.Type: GrantFiled: June 7, 2004Date of Patent: November 17, 2009Assignee: HUMANAUTOCELL GmbHInventors: Martin Goerne, Peter Matthias Kaufmann
-
Patent number: 7618647Abstract: Methods, systems, and uses of bucky paper are provided in the present invention. These embodiments include covering medical implants with single or multiple layers of bucky paper, treating bucky paper with various therapeutics to be released through the bucky paper to a target site, shaping bucky paper into non-conventional configurations for improved therapeutic deliver, and using bucky paper alone or in conjunction with other materials to treat a target site.Type: GrantFiled: October 3, 2003Date of Patent: November 17, 2009Assignee: Boston Scientific Scimed, Inc.Inventors: Jan Weber, Tom Holman, Tracee Eidenschink, John Jianhua Chen
-
Publication number: 20090269389Abstract: ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modified to secrete the protein of choice; have a long life span; are of human origin; have good in vivo device viability; deliver efficacious quantity of growth factor; trigger no or low level host immune reaction, and are non-tumorigenic.Type: ApplicationFiled: July 7, 2009Publication date: October 29, 2009Applicant: NEUROTECH USA, INC.Inventors: Weng Tao, David H. Rein, Brenda J. Dean, Paul F. Stabila, Moses B.I. Goddard
-
Publication number: 20090263454Abstract: Effective treatments of pain and/or inflammation are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist and at least one beta adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation.Type: ApplicationFiled: April 15, 2009Publication date: October 22, 2009Applicant: WARSAW ORTHOPEDIC, INC.Inventors: John M. Zanella, Sara Waynick
-
Publication number: 20090263453Abstract: Methods and compositions are provided for reducing, treating or preventing pain and/or inflammation in a patient in need of such treatment, the methods and compositions comprising administering a therapeutically effective amount of a statin or pharmaceutically acceptable salt thereof to a target tissue site beneath the skin.Type: ApplicationFiled: April 18, 2008Publication date: October 22, 2009Applicant: Warsaw Orthopedic, Inc.Inventors: William McKay, John Zanella
-
Publication number: 20090248172Abstract: The invention relates to a membrane comprising a biocompatible block copolymer and has a porous structure with regularly distributed pores. A method for preparing said membranes is also provided.Type: ApplicationFiled: May 30, 2007Publication date: October 1, 2009Applicant: EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICHInventor: Peter Neuenschwander
-
Publication number: 20090238855Abstract: The invention is to articles of extracellular matrix. The articles comprise one or more sheets of mammalian extracellular matrix laminated together. A single sheet can be folded over and laminated on 3 sides. Two or more sheets can be laminated to each other at their edges. The sheets can further encase a composition comprising a cell or cells, such as for example, a stem cell. A single sheet can be folded over to encase a composition, or rolled to encase a composition with lamination at either end of the roll, for example. The invention also includes methods of using these articles to regenerate tissue at tissue defects, or heal wounds in damaged tissue.Type: ApplicationFiled: February 27, 2009Publication date: September 24, 2009Inventor: Robert G. Matheny
-
Publication number: 20090238856Abstract: A polymeric composition comprising a polysulfone polymer and an elastomeric polymer for use as a coating composition for coating an implantable device, such as a DES, and methods of making and using the implantable device are provided.Type: ApplicationFiled: June 2, 2009Publication date: September 24, 2009Inventors: Charles D. Claude, Ni Ding, Yeung Siu Yu
-
Patent number: 7592016Abstract: Method for preparing an implantable device for a sustained delivery of a substance within a body of a human or an animal subject, the method including; dissolving a biocompatible polymer in a suitable solvent solution to produce a polymer-solvent solution; adding the substance to the polymer-solvent solution to produce a polymer-solvent solution-substance admixture; drying the polymer-solvent solution-substance admixture to form a substantially dry mass; and one or more of the following three steps: (1) adding a second polymer-solvent solution-substance admixture to the dry mass and this second polymer-solvent solution-substance admixture is then allowed to dry; and/or, (2) refrigerating the mass; and/or, (3) adding a liquid to the mass to cause the mass to soften and thereafter manipulating the softened mass to a desired shape.Type: GrantFiled: February 5, 2004Date of Patent: September 22, 2009Assignee: Regents of The University of CaliforniaInventors: Corinne Gail Wong, Hung Tao Hsu, Ricardo Azevedo Pontes de-Carvalho
-
Patent number: 7585516Abstract: A polymer coating for medical devices based on a polyolefin derivative. A variety of polymers are described to make coatings for medical devices, particularly, for drug delivery stents. The polymers include homo-, co-, and terpolymers having at least one olefin-derived unit and at least one unit derived from vinyl alcohol, allyl alcohol and derivatives thereof.Type: GrantFiled: November 12, 2001Date of Patent: September 8, 2009Assignee: Advanced Cardiovascular Systems, Inc.Inventor: Stephen Dirk Pacetti
-
Patent number: 7585320Abstract: A medical device and system capable of providing on-demand delivery of biologically active material to a body lumen patient, and a method of making such medical device. A first coating layer comprising a biologically active material and optionally a polymeric material is disposed on the surface of the medical device. A second coating layer comprising magnetic particles and a polymeric material is disposed on the first coating layer. The second coating layer, which is substantially free of a biologically active material, protects the biologically active material prior to delivery. The system includes the medical device and a source of energy, such as an electromagnetic or mechanical vibrational energy. When the patient is exposed to the energy source, the magnetic particles move out of the second coating layer and create channels therein through which the biologically active material can be released.Type: GrantFiled: September 1, 2006Date of Patent: September 8, 2009Assignee: Boston Scientific Scimed, Inc.Inventors: Mark A Hamm, Louis J Barbato, Robert J Crowley, Wendy Naimark, Hatal Patel
-
Publication number: 20090202608Abstract: The present invention relates to osmotic delivery devices, formulations, and methods for delivery of two or more beneficial agents. In one aspect, the present invention provides osmotic delivery devices useful for substantially concurrent administration of two or more beneficial agents. In another aspect, the present invention provides beneficial agent formulations for use in the osmotic delivery devices. The formulations include formulations wherein beneficial agents are soluble in the vehicle, suspension formulations comprising particle formulations of one or more beneficial agent, and combinations thereof. Further, methods for treatment of a variety of diseases or conditions using two or more beneficial agents are disclosed, wherein the methods are preferably practiced using the osmotic delivery devices and/or formulations of the invention.Type: ApplicationFiled: February 12, 2009Publication date: August 13, 2009Inventors: Thomas R. Alessi, Karling Alice Leung, Ryan D. Mercer, Cristina G. Negulescu, Catherine M. Rohloff, Bing Yang
-
Patent number: 7556822Abstract: A method of preparing intraocular lenses in situ is disclosed. The method involves the injection of an unsaturated macromonomer of Formula I: The macromonomer is then polymerized to give a polymer suitable for use in an intraocular lens.Type: GrantFiled: January 24, 2008Date of Patent: July 7, 2009Assignee: Commonwealth Scientific and Industrial Research OrganisationInventors: Anthony Brian Clayton, Gordon Francis Meijs
-
Patent number: 7541048Abstract: A coating composition and related method for use in applying a bioactive agent to a surface in a manner that will permit the bioactive agent to be released from the coating in vivo. The composition is particularly well suited for coating the surface of implantable medical device, such as a stent or catheter, in order to permit the device to release bioactive agent to the surrounding tissue over time. The composition includes a plurality of compatible polymers having different properties that can permit them to be combined together to provide an optimal combination of such properties as durability, biocompatibility, and release kinetics.Type: GrantFiled: April 6, 2005Date of Patent: June 2, 2009Assignee: SurModics, Inc.Inventors: David M. DeWitt, Michael J. Finley, Laurie R. Lawin
-
Publication number: 20090136465Abstract: The present invention relates to methods and compositions for treating, ameliorating or preventing a disease or disorder in a subject by introducing into cells of the subject a therapeutic gene switch construct that controls expression of one or more therapeutic products.Type: ApplicationFiled: September 29, 2008Publication date: May 28, 2009Applicant: INTREXON CORPORATIONInventors: Bethany Lynn Merenick, Robert P. Beech, Thomas D. Reed, Anna P. Tretiakova, Richard E. Peterson
-
Patent number: 7531670Abstract: Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided.Type: GrantFiled: December 1, 2004Date of Patent: May 12, 2009Assignee: Sprectrum Pharmaceuticals, Inc.Inventors: Alvin Jerald Glasky, David B. Fick, David R. Helton
-
Publication number: 20090117170Abstract: The present invention of a segmented release device (sandwich construction with reservoir) for molecules (active compounds, medicaments, diagnostic, therapeutic and chemical reagents) is based on a construction which makes possible a constant release rate through diffusion-permeable intersegment films partially or completely filled with liquid of the neighboring media. The molecules pass here from the reservoir of the device into the outer medium by diffusion exclusively through the intersegment films. These intersegment films are adjustable in their thickness and composition in the manner specified in each case. The release rate can be determined in advance and thus also calculated within wide limits by the structure and geometry of the segmented device and by the number, composition and dimensions of the thin intersegment films. The device according to the present invention allows the adjustment of an extremely precise release rate of the molecules.Type: ApplicationFiled: October 12, 2005Publication date: May 7, 2009Applicant: CAPSULUTION NANOSCIENCE AGInventors: Lutz Kroehne, Andreas Voigt
-
Publication number: 20090104247Abstract: Provided herein are coating designs for the tailored release of two therapeutic agents from polymer coatings and methods of making and using the same.Type: ApplicationFiled: October 23, 2007Publication date: April 23, 2009Inventor: Stephen D. Pacetti
-
Publication number: 20090098186Abstract: A multi-layer drug coated medical device such as for example an expandable vascular drug eluting stent is formed by vacuum pulse spray techniques wherein each layer is irradiated to improve adhesion and/or drug elution properties prior to formation of subsequent layers. Layers may be homogeneous or of diverse drugs. Layers may incorporate a non-polymer elution-retarding material. Layers may alternate with one or more layers of non-polymer elution-retarding materials. Polymer binders and/or matrices are not used in the formation of the coatings, yet the pure drug coatings have good mechanical and elution rate properties. Systems, methods and medical device articles are disclosed.Type: ApplicationFiled: October 1, 2008Publication date: April 16, 2009Applicant: EXOGENESIS CORPORATIONInventors: Sean R. Kirkpatrick, Richard C. Svrluga
-
Publication number: 20090087474Abstract: The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on secreted therapeutic proteins, NsG29 and NsG31. NsG29 and Ns31 are members of a newly identified family of growth factors with a specific cystein pattern and characterised by expression in the nervous system. The secreted growth factors have potential for the treatment of disorders of the nervous system. The invention also relates to bioactive NsG29 and NsG31 polypeptide fragments and the corresponding encoding DNA sequences.Type: ApplicationFiled: January 9, 2006Publication date: April 2, 2009Inventors: Thomas N. Petersen, Nikolaj Blom, Mette Gronborg, Philip Kusk, Soren Brunak, Teit E. Johansen, Lars U. Wahlberg
-
Patent number: 7510725Abstract: The invention relates to dura substitutes to be used as prostheses for dural defects in the field of neurosurgery and processes for producing the same. The present invention provides artificial dura mater materials comprising sheets of microbial-derived polysaccharide processed to have the necessary strength characteristics, conformability and physical properties.Type: GrantFiled: April 15, 2008Date of Patent: March 31, 2009Assignee: Synthes USA, LLCInventors: Christopher James Damien, Heather Ann Beam, Gerry Ann Oster, Frederic S. Wright, Gonzalo Serafica
-
Patent number: 7498042Abstract: A luminal stent, implanted and implanted and left in the blood vessel, is disclosed. By permitting a stent (1), formed of a biodegradable polymer material (2), to be swollen, and by impregnating the swollen stent (1) with a drug, a sufficient quantity of the drug is impregnated in the stent. This drug is continuously released into the blood vessel over a prolonged time. A biodegradable polymer layer is formed on the surface of the stent (1) impregnated with the drug, and the release rate of the drug impregnated in the stent is controlled.Type: GrantFiled: August 8, 2001Date of Patent: March 3, 2009Assignee: Kyoto Medical Planning Co., Ltd.Inventors: Keiji Igaki, Hideki Yamane
-
Patent number: 7494802Abstract: The present invention relates to a biopolymer covering for a tissue surface including, for example, a dressing, a bandage, a drape such as a bandage contact lens, a composition or covering to protect tissue, a covering to prevent adhesions, to exclude bacteria, to inhibit bacterial activity, or to promote healing or growth of tissue. An example of such a composition is an amniotic membrane covering for an ocular surface. Use of a covering for a tissue surface according to the invention eliminates the need for suturing. The invention also includes devices facilitating the fastening of a membrane to a support, culture inserts, compositions, methods, and kits for making and using coverings for a tissue surface and culture inserts. Compositions according to the invention may include cells grown on a membrane or attached to a membrane, and such compositions may be used as scaffolds for tissue engineering or tissue grafts.Type: GrantFiled: March 14, 2003Date of Patent: February 24, 2009Assignee: TissueTech, Inc.Inventors: Scheffer C. G. Tseng, Helga Sandoval, William G. Lee
-
Publication number: 20090047325Abstract: Disclosed are compositions and methods for the xenotransplantation treatment of neurological diseases of the central nervous system of a mammal.Type: ApplicationFiled: October 9, 2008Publication date: February 19, 2009Applicant: NEUROTROPHINCELL PTY. LIMITEDInventors: Robert Bartlett Elliot, Stephen John Martin Skinner, Alfred Vasconcellos, Dwaine Emerich, Cesar Venturina Borlongan, Christopher Edward Williams
-
Publication number: 20090035350Abstract: The present invention is directed to polymeric compositions comprising a biodegradable copolymer that possesses shape-memory properties and implantable devices (e.g., drug-delivery stents) formed of materials (e.g., a coating) containing such compositions. The polymeric compositions can also contain at least one non-fouling moiety, at least additional biocompatible polymer, at least one biobeneficial material, at least one bioactive agent, or a combination thereof. The polymeric compositions are formulated to possess good mechanical, physical and biological properties. Moreover, implantable devices formed of materials comprising such compositions can be delivered to the treatment site in a conveniently compressed size and then can expand to dimensions appropriate for their medical functions.Type: ApplicationFiled: August 3, 2007Publication date: February 5, 2009Inventors: John Stankus, Mikael Trollsas, Michael Ngo
-
Publication number: 20090010991Abstract: A drug coated nasal stent implant that provides filtration of environmental pollutants and airborne allergens from inhaled air regulating the air before it is ingested into the remainder of the respiratory tract.Type: ApplicationFiled: June 2, 2008Publication date: January 8, 2009Inventors: Julian Prabhu, Luan M. Prabhu, Sean C. Prabhu, Andre J. Prabhu
-
Patent number: 7473431Abstract: An injectable slow-release methadone, partial opioid agonist or opioid antagonist formulation is provided comprising methadone, a partial opioid agonist or opioid antagonist in a poly(D,L-lactide) excipient with a small amount of residual ethyl acetate. Upon intramuscular or subcutaneous injection of the composition, methadone, a partial opioid agonist or opioid antagonist is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances. Of particular interest are the drugs buprenorphine, methadone and naltrexone.Type: GrantFiled: December 17, 2002Date of Patent: January 6, 2009Assignee: Brookwood Pharmaceuticals, Inc.Inventors: Thomas R. Tice, Jay K. Staas, Teresa M. Ferrell, Peter Markland